EUVIMEDOpdag EUVIMED
Crossref

Optimizing Endosomal Escape for Effective Aptamer-Based Ubiquitin-Mediated Degradation of c-Met

Yuan Liu, Mengyuan Jiang, Juncai Li, Lizhuan Zhang, Chao Zuo, Hui Zhang iD, Weihong Tan iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c09554 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2026. Written by Yuan Liu and 6 co-authors. Institution: School of Molecular Medicine, Hangzhou Institute for Advanced Study, UCAS, Hangzhou310024, China. Major MEDLINE topics: Endosomes, Aptamers, Nucleotide, Ubiquitin, Proto-Oncogene Proteins c-met. 68 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, University of Chinese Academy of Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Endosomal escape is a significant challenge in the delivery of nucleic acid therapeutics, which also limits the cytosolic activity of aptamers that bind membrane proteins and enter cells by endocytosis. Here, we systematically mapped the colocalization of the c-Met targeting aptamer SL1 with early, recycling, and late endosomes following endocytosis, revealing predominant endosomal retention with minimal cytosolic release. We further evaluated two endosomal escape agents, the small molecule chloroquine and the peptide GALA, and found that chloroquine more effectively facilitates aptamer endosomal escape. To functionally exploit enhanced cytosolic delivery, we developed an aptamer-based PROTAC that promotes the interaction of the membrane protein c-Met with an E3 ligase, leading to its ubiquitination. With enhanced endosomal escape, this system achieved ubiquitin-mediated degradation of c-Met, inhibited proliferation and migration of target cells, and suppressed tumor growth in a xenograft model. These results link optimized endosomal escape to intracellular aptamer function and establish a strategy for membrane protein degradation via the ubiquitin-proteasome pathway.

Subjects

MeSH terms (MEDLINE)

EndosomesAptamers, NucleotideUbiquitinProto-Oncogene Proteins c-metHumansAnimalsMiceProteolysis Targeting ChimeraCell Line, TumorProteolysisEndocytosisUbiquitinationChloroquineMice, NudeCell Proliferation

Author keywords

PROTACsaptamerendosomal escapeendosomesprotein degradation

Substances

Aptamers, NucleotideUbiquitinProto-Oncogene Proteins c-metProteolysis Targeting ChimeraChloroquine

Authors and institutions

  • School of Molecular Medicine, Hangzhou Institute for Advanced Study, UCAS, Hangzhou310024, China.
  • The Cancer Hospital of the Hangzhou Institute of Medicine (Zhejiang Cancer Hospital), Zhejiang Key Laboratory of Functional Nucleic Acids for Basic and Clinical Application, Hangzhou Institute of Medicine (HIM), Chinese…
  • Medical School, University of Chinese Academy of Sciences, Beijing100049, China.

ORCID profiles: Hui Zhang, Weihong Tan

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • University of Chinese Academy of Sciences
  • Zhejiang Province Soft Science Research Program

Cite

APA

Liu, Y., Jiang, M., Li, J., Zhang, L., Zuo, C., Zhang, H., & Tan, W. (2026). Optimizing Endosomal Escape for Effective Aptamer-Based Ubiquitin-Mediated Degradation of c-Met. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c09554

Vancouver

Liu Y, Jiang M, Li J, Zhang L, Zuo C, Zhang H, et al. Optimizing Endosomal Escape for Effective Aptamer-Based Ubiquitin-Mediated Degradation of c-Met. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c09554

BibTeX
@article{Liu2026,
  author = {Liu, Yuan and Jiang, Mengyuan and Li, Juncai and Zhang, Lizhuan and Zuo, Chao and Zhang, Hui and Tan, Weihong},
  title = {Optimizing Endosomal Escape for Effective Aptamer-Based Ubiquitin-Mediated Degradation of c-Met},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c09554}
}
Start for free →